ProCE Banner Activity


Another Tool in the Toolbox: Updates on Improving Renal and Cardiovascular Outcomes in CKD in T2D


Join expert faculty for a 1-hour interactive program reviewing the evidence and benefits of mineralocorticoid receptor antagonists (MRA) for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). Learn about key clinical trial results that led to the approval of finerenone, the newest MRA, as well as its place in therapy and how to select appropriate patients for its use.

Physician Assistants: maximum of 1.00 hours of AAPA Category 1 CME credits Registered Nurses: 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit

Released: May 23, 2022

Expiration: May 22, 2023

No longer available for credit.



George L. Bakris

George L. Bakris, MD

Professor of Medicine
American Heart Association Comprehensive Hypertension Center
Department of Medicine
University of Chicago Medicine
Chicago, Illinois

Lucia M Novak

Lucia M Novak, MSN, ANP-BC, BC-ADM

President, Diabesity, LLC
North Bethesda, Maryland
Co-Executive Director, Capital Health and Metabolic Center
Capital Diabetes and Endocrine Associates
Camp Springs and Silver Spring, Maryland


This activity is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

Provided by

ProCE Banner


Bayer HealthCare Pharmaceuticals Inc.

Target Audience

NPs and PAs in Primary Care

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply guideline-recommended CKD screenings to patients with T2D

  • Discuss the adverse cardiovascular outcomes associated with CKD in T2D

  • Identify patients who may benefit from nonsteroidal MRAs to improve renal and cardiovascular outcomes in T2D


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

George L. Bakris, MD: consultant/advisor/speaker: Alnylam, AstraZeneca, Bayer, DiaMedica Therapeutics, Horizon, Ionis, KBP Biosciences, Merck, Novo Nordisk, Quantum Genomics.

Lucia M. Novak, MSN, ANP-BC, BC-ADM: consultant/advisor/speaker: Abbott Diabetes Care, Boehringer Ingelheim/Lilly, Novo Nordisk, Provention Bio, Xeris.

None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 67%.

The estimated time to complete this activity is 1.00 hour.

Release date: May 23, 2022
Expiration date: May 22, 2023


Interactive, audio-enhanced slide lecture


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until May 22, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA Course Advisor: Daniel Forsberg, PA-C, MPH, CPH, Touro College Illinois, Skokie, Illinois

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.